Persons Reported to be living with HIV infection and with AIDS reported

Year Adults/Adolescents Children Under 13 Years old Total Cumulative Totals
  HIV AIDS HIV AIDS HIV AIDS Adults / Adolescents Children Under 13 Years old Total
2000 4,104 2,210 38 23 4,142 2,125 6,206 61 6,267
2001

4,228

2,320

37 21 4,265 2,241 6,548 58 6,606
2002 4,565 2,581 50 20 4,615 2,602 7,146 70 7,217
                   
 

HIV Infection Cases  from areas with confidential HIV infection reporting

Year   Cumulative Totals
    Adults / Adolescents Children Under 13 Years old Total
2000 459 4,307 49 4,356
2001 408 4,447 49 4,496
2002 383 4,565 50 4,615
         

 

Adult/Adolescent HIV infection and AIDS cases reported in the United States

Year Males Females
  HIV AIDS HIV AIDS
2000 288 294 166 137
2001 258 301 192 116
         
 

New Pediatric AIDS cases reported

Year
2000 1
2001 3

 


Cumulative AIDS Cases

Cumulative Number of AIDS Cases, Reported through 2002 5,293
Cumulative Number of Adult/Adolescent AIDS Cases, Reported through 2002 5,236
Cumulative Number of AIDS Cases in Children <13, Reported through 2002 57

Distribution of Cumulative Adult/Adolescent AIDS Cases by Gender, Reported through June 2002

  MS USA
Men 3,922 680,909
Women 1,093 146,298
Total 5,015 827,208

 

New AIDS Cases

New AIDS Cases, Reported through 2002 433
New Adult/Adolescent AIDS Cases, Reported in 2001 417
New AIDS Cases in Children <13, Reported through December 2001 1

Distribution of New Adult/Adolescent AIDS Cases by Gender, Reported in 2001

  MS USA
Men 301 31,901
Women 116 11,082
Total 417 42,983

 

Persons Living with AIDS

Estimated Number of Persons Living with AIDS at the End of 2002 2,602
Estimated Number of Adults/Adolescents Living with AIDS at the End of 2002 2,581
Estimated Number of Children Living with AIDS at the End of 2002 20
HIV Infection Cases Reported in 2002 383

 

Total Deaths Reported through 2000, due to AIDS = 2,524
HIV Reporting Requirements ?   Yes, Name Based.
 
HIV Testing Options?  Confidential testing Only
Definitions:
Anonymous test: Individual does NOT use their name, and a name is not associated with test result. Anonymous tests are offered at anonymous testing centers, available in many, but not all, states.
Confidential test: Individual DOES use their name. If test is positive, individual's name will be known to their health care provider and, potentially, to other health care professionals and, in some cases, your state's Department of Health.
 
HIV Testing for Mothers and Newborns
Voluntary or Mandatory Testing?
 
Voluntary HIV testing; no specific law. State follows CDC guidelines; No specific law or language on testing for mothers and newborns.
Voluntary HIV Testing: All states and the District of Columbia have certified to the CDC that they have measures in place to implement the CDC's 1995 recommendations on HIV counseling and testing of pregnant women.  The CDC's 1995 recommendations state that HIV testing of pregnant women and infants should be voluntary and providers must obtain informed consent for testing as required by their state laws.  Voluntary testing is noted if the state follows the CDC guidelines but does not have specific guidelines for testing of mothers and newborns.
 
Status of State Medicaid Expansion Efforts for People with HIV
Approved 1115 Waiver, TWWIIA demonstration?
YEs, Has received approval for a TWWIIA demonstration.
Definitions:
1115 Waivers: Section 1115 of the Social Security Act authorizes the executive branch of the Federal government to waive the statutory and regulatory provisions of the Medicaid program. States have used "1115 waivers" to make changes in eligibility, benefits, and other areas of their Medicaid programs. The Centers for Medicare and Medicaid Services (CMS--formerly known as the Health Care Financing Administration) and several states have been analyzing the implications of expanding Medicaid eligibility to people with HIV prior to disability through the use of Section 1115 waivers of the Social Security Act. To use 1115 waivers, states face several challenges, particularly the need to demonstrate "budget neutrality" to the Medicaid program - that the costs of an expansion over a designated period of time (usually 5 years) would not exceed the costs to Medicaid in the absence of the expansion.
Ticket to Work/Work Incentives Improvement Act of 1999: TWWIIA expanded State options under Medicaid by creating new Medicaid buy-in options for working individuals with disabilities and extended Medicare cover-age for working individuals with disabilities. The Act also authorized state demonstration programs to provide Medicaid to workers with potentially severe disabilities, including HIV/AIDS, who are not yet disabled but whose health conditions could be expected to cause disability.
Notes: Most people with HIV who qualify for Medicaid do so by meeting the program’s income and disability standards once their illness has already progressed. Many low income people with HIV may be faced with of having their eligibility postponed until they become disabled, even though there are therapies available that may prevent disability and national treatment guidelines recommend access to early treatment. 1115 Waivers and TWWIIA demonstrations are two ways in which states have sought to address this limitation.

 

Sterile Syringe Exchange Programs?  No

Notes:
U.S. totals include data from the United States (50 states and the District of Columbia), and from U.S. dependencies, possessions, and independent nations in free association with the United States.
Definitions: Programs in operation: includes both state-sanctioned syringe exchange programs and non-sanctioned programs. Because their operation may not necessarily be authorized, it is difficult to account for an exact number of syringe exchange programs operation across the country; therefore, the list may not be comprehensive.
 
STD/HIV/AIDS Education Requirement?  No, If taught voluntarily, must stress abstinence. State law allows localities to override the state's requirements for which topics must be taught, including abstinence; however, the law states that "no program or instruction may include anything that contradicts the excluded components." Also, State specifically authorizes localities to teach about contraception, but if taught, it must include failure rates or effectiveness and failure rates among adolescents.
 
Minors' Right to Consent to HIV/STD Services?  Yes. State officially classifies HIV/AIDS as an STD or infectious disease, for which minors may consent to testing and treatment.
 

 

Total Ryan White Funding, FY2000   $8,454,650 FY2002  $12,504,167

 

CDC HIV Prevention Funding for States
 FY2001 
$2,085,558

FY2003   $2,141,975

 

Total Federal and State Funding for ADAP, FY2001  $4,962,283

Definitions: ADAPs: AIDS Drug Assistance Programs (ADAPs), authorized under Title II of the Ryan White Comprehensive AIDS Resources Emergency (CARE) Act, provide HIV-related prescription drugs to underinsured and uninsured individuals living with HIV/AIDS. Each state or territory administers its own ADAP.

 

AIDS Drug Assistance Programs (ADAPs)
Source Kaiser Family Foundation

Total ADAP Clients Served, June 2002  
  MS
#
US
#
   504 80,035

 
ADAP Clients Served by Sex, June 2002  
 NA1= Data was not reported by the state. MS
#
MS
%
US
#
US
%
  Male NA 1 NA 1 62,034 78
  Female NA 1 NA 1 16,702 21
  Total 504 100 79,531 100

 
ADAP Clients Served by Race/Ethnicity, June 2002  
NA1= Data was not reported by the state. MS
#
MS
%
US
#
US
%
  White NA 1 NA 1 29,426 37
  Black NA 1 NA 1 26,245 33
  Hispanic NA 1 NA 1 19,883 25
  Asian/Pacific Islander NA 1 NA 1 795 1
  American Indian/Alaskan Native NA 1 NA 1 795 1
  Other NA 1 NA 1 795 1
  Total 504 100 79,531 100

 
ADAP Clients Served by Age, June 2002  
 NA1= Data was not reported by the state. MS
#
MS
%
US
#
US
%
  <13 years old NA 1 NA 1 795 1
  13-19 years old NA 1 NA 1 0 2 0 2
  20-44 years old NA 1 NA 1 50,105 63
  >44 years old NA 1 NA 1 27,836 35
  Total 504 50,400 79,531 100

 
ADAP Clients Served by Income, June 2002  
 NA1= Data was not reported by the state. MS
#
MS
%
US
#
US
%
  <100% FPL NA 1 NA 1 38,175 48
  101-200% FPL NA 1 NA 1 26,245 33
  201-300% FPL NA 1 NA 1 8,748 11
  301-400% FPL NA 1 NA 1 3,181 4
  >400% FPL NA 1 NA 1 1,591 2
  Total 504 50,400 79,531 100

 
Insurance Coverage of ADAP Clients, June 2002  
 NA1= Data was not reported by the state. MS
#
MS
%
US
#
US
%
  Medicaid NA 1 NA 1 0 10
  Medicare NA 1 NA 1 0 6
  Private NA 1 NA 1 0 13

 
National ADAP Budget, Total Federal and State Sources, FY 2002  
  MS
$
US
$
   6,409,356 878,610,754

 
National ADAP Budget by Source, FY 2002  
  MS
$
MS
%
US
$
US
%
  ADAP Earmark 4,566,348 71 619,830,000 71
  Title II Base 1,093,008 17 28,886,192 3
  State 750,000 12 160,385,979 18
  Title I 0 0 19,736,619 2
  Other Federal 0 0 30,941,439 4
  ADAP Supplemental Grants 0 0 19,170,000 2
  Total 6,409,356 100 878,610,754 100

 
Total ADAP Drug Expenditures, June 2002  
  MS
$
US
$
   412,073 70,705,142

 
ADAP Drug Expenditures by Drug Class, June 2002  
  MS
$
MS
%
US
$
US
%
  Nucleoside Reverse Transcriptase Inhibitors 206,533 50 31,486,146 49
  non-Nucleoside Reverse Transcriptase Inhibitors 70,090 17 7,940,575 12
  Protease Inhibitors 93,112 23 16,433,502 25
  Opportunistic Infections/Other 42,338 10 9,015,329 14
  Total 412,073 100 64,875,793 100

 
Total ADAP Prescriptions Filled, June 2002  
  MS
#
US
#
   Data was not reported by the state. 257,279

 
ADAP Prescriptions Filled by Drug Class, June 2002  
 NA3= State did not report data. MS
#
MS
%
US
#
US
%
  Nucleoside Reverse Transcriptase Inhibitors NA 3 NA 3 83,166 36
  non-Nucleoside Reverse Transcriptase Inhibitors NA 3 NA 3 23,933 10
  Protease Inhibitors NA 3 NA 3 33,813 15
  Opportunistic Infections/Other NA 3 NA 3 87,746 38
  Total NA 3 NA 3 228,771 100

 
Federal ADAP Funds Used for Insurance Purchasing/Maintenance, FY 2002  
  MS
$
US
$
   NA 18,486,544

 
ADAP Formularies, Number of Medications by Drug Class, 2002  
  MS
#
US
#
  Nucleoside Reverse Transcriptase Inhibitors 9 NA
  Protease Inhibitors Covered 6 NA
  Non-nucleosides Covered 2 NA
  OI Prophylaxis Covered 10 NA
  Other Medications Covered 16 NA
  Total 43 NA

 
ADAP Emergency Cost Containment Measures, February 2003  
  MS
 
US
 
  Has ADAP Emergency Cost Containment Measures in Place No 16 Yes
  Notes